Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging

Simon Kaller, Michael Rullmann, Marianne Patt, +10

European Journal of Nuclear Medicine and Molecular Imaging

Positron Emission TomographyNeuroimaging BiomarkersMedicinePet-mriNeuropharmacology +7

PET Quantification of ¹⁸F-Florbetaben Binding to β-Amyloid Deposits in Human Brains

Georg Becker, Masanori Ichise, Henryk Barthel, +8

Journal of Nuclear Medicine

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography

Kai Kendziorra, Henrike Wolf, Philipp Meyer, +10

European Journal of Nuclear Medicine and Molecular Imaging

Positron Emission TomographyNeurodegenerative DiseasesAlzheimer's DiseaseMedicineNeurochemical Biomarkers +7

Central noradrenaline transporter availability in highly obese, non-depressed individuals

Swen Hesse, Georg‐Alexander Becker, Michael Rullmann, +16

European Journal of Nuclear Medicine and Molecular Imaging

ObesityMetabolic SyndromeMetabolic DisorderPhysiologyObesity Management +5

Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls

Henryk Barthel, Julia Luthardt, Georg Becker, +15

European Journal of Nuclear Medicine and Molecular Imaging

Neurodegenerative DiseasesAlzheimer's DiseaseMechanism Phase 0Brain β-Amyloid BurdenBiomarkers +7

Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease

Solveig Tiepolt, Swen Hesse, Marianne Patt, +7

European Journal of Nuclear Medicine and Molecular Imaging

Neuroimaging BiomarkersNeurodegenerative DiseasesSurrogate BiomarkerAlzheimer's DiseaseNeuronal Injury +8

Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer’s dementia

Osama Sabri, Philipp Meyer, Susanne Gräf, +18

Brain

NeuropsychologySynaptic TransmissionNeurochemical BiomarkersSynaptic SignalingSocial Sciences +21

Altered serotonin transporter availability in patients with multiple sclerosis

Swen Hesse, Franziska Moeller, David Petroff, +10

European Journal of Nuclear Medicine and Molecular Imaging

NeurophysiologyNeurological DisorderNeuropharmacologyNeurologyNeuroscience +3

P2Y1 receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex

Julia Luthardt

Neurochemistry International

Parietal CortexNeurophysiologyNeuroanatomySynaptic TransmissionPhysiology +10

Partial-Volume Effect Correction Improves Quantitative Analysis of ¹⁸F-Florbetaben β-Amyloid PET Scans

Michael Rullmann, Juergen Dukart, Karl‐Titus Hoffmann, +9

Journal of Nuclear Medicine